Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR-IMHA Inclusive Research Excellence Prizes-Indigenous Health Research

University of Alberta

$25,000.00

Introducing a Portable Ultrasound AI-Enhanced Hip Dysplasia Screening Tool into Indigenous Clinics and Communities

FY 2024-25

Summary
Developmental hip dysplasia (DDH) is a condition that affects about 2% of babies, with much higher rates in Indigenous populations. If caught early, it can usually be treated by wearing a special harness. But if it's missed, it can cause serious problems like early arthritis, the need for multiple surgeries, and even hip replacement at a young age. The best time to treat DDH is before the baby is 3 months old, but current screening methods often fail. Physical exams aren't always accurate, and ultrasounds-the best tool for diagnosis-aren't available in many places, especially in Indigenous communities. In Canada, Indigenous populations are thought to have much higher rates of DDH, possibly 6 to 30 times more than the general population. However, many Indigenous families face challenges in getting their babies screened. These include living in remote areas and having limited access to healthcare. These barriers make it harder to diagnose and treat DDH early, leading to more severe health problems later. To help solve this issue, we created a portable ultrasound device that uses artificial intelligence (AI). This device is affordable, easy to use, and accurate, making it possible to screen babies for DDH even in remote communities. Between June 2023 and December 2024, we worked with three Indigenous clinics in Alberta to initiate the implementation of the Newborn Arthritis Prevention Screening (NAPS) Program. During this time, 203 babies were screened, and seven cases of DDH were found. Six of these cases had no known risk factors and would likely have been missed without this tool. This project was done in close partnership with Indigenous communities. We followed OCAP® principles, which make sure that Indigenous nations control their health data and that the program respects their cultural values and needs. Our goal is to grow this program and support local communities so more babies can get the care they need for a healthy start in life.
Program
CIHR-IMHA Inclusive Research Excellence Prizes-Indigenous Health Research
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530787
Name
Jaremko Jacob L
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Other : CIHR-IMHA Inclusive Research Excellence Prizes
Projecttitle
Introducing a Portable Ultrasound AI-Enhanced Hip Dysplasia Screening Tool into Indigenous Clinics and Communities
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$25,000
Cihrequipment2
$0
Programname2
CIHR-IMHA Inclusive Research Excellence Prizes-Indigenous Health Research
Keyworddelim
Artificial Intelligence; Hip Dysplasia Screening; Implementation Science; Indigenous Health; Portable Ultrasound; Rural Healthcare
Abstract
Developmental hip dysplasia (DDH) is a condition that affects about 2% of babies, with much higher rates in Indigenous populations. If caught early, it can usually be treated by wearing a special harness. But if it's missed, it can cause serious problems like early arthritis, the need for multiple surgeries, and even hip replacement at a young age. The best time to treat DDH is before the baby is 3 months old, but current screening methods often fail. Physical exams aren't always accurate, and ultrasounds-the best tool for diagnosis-aren't available in many places, especially in Indigenous communities. In Canada, Indigenous populations are thought to have much higher rates of DDH, possibly 6 to 30 times more than the general population. However, many Indigenous families face challenges in getting their babies screened. These include living in remote areas and having limited access to healthcare. These barriers make it harder to diagnose and treat DDH early, leading to more severe health problems later. To help solve this issue, we created a portable ultrasound device that uses artificial intelligence (AI). This device is affordable, easy to use, and accurate, making it possible to screen babies for DDH even in remote communities. Between June 2023 and December 2024, we worked with three Indigenous clinics in Alberta to initiate the implementation of the Newborn Arthritis Prevention Screening (NAPS) Program. During this time, 203 babies were screened, and seven cases of DDH were found. Six of these cases had no known risk factors and would likely have been missed without this tool. This project was done in close partnership with Indigenous communities. We followed OCAP® principles, which make sure that Indigenous nations control their health data and that the program respects their cultural values and needs. Our goal is to grow this program and support local communities so more babies can get the care they need for a healthy start in life.
Competitiondate
202502
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jaremko, Jacob L; Gallant, Cassandra
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $25,000~ $0~